← back to search

James Ferguson

Ludwig Boltzmann Institute for Digital Health and Prevention · US
Area of research
Hepatology · Surgery
Research interest
Research interests include Liver Disease and Transplantation, Organ Transplantation Techniques and Outcomes, Liver Disease Diagnosis and Treatment, and Liver Diseases and Immunity.
h-index
39
citations
6,476
works
207
NIH funding
primary concept
Medicine
email

Recent publications

Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.
2026cited by 2position: contributordoi
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial).
2025cited by 5position: contributordoi
The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT
Efficacy and Mechanism Evaluation 2025cited by 1position: contributordoi
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study.
2025cited by 0position: contributordoi
The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT
2025cited by 0position: contributor
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes.
2024cited by 23position: contributordoi
Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood.
2024cited by 14position: contributordoi
UK guideline on the transition and management of childhood liver diseases in adulthood.
2024cited by 8position: contributordoi
MAP9/MAPH-9 supports axonemal microtubule doublets and modulates motor movement
Developmental Cell 2023cited by 14position: middledoi
Where does genetic testing fit in the diagnostic pathway of patients with cryptogenic cirrhosis?
2023cited by 3position: contributordoi
Using global burden of hepatocellular cancer and liver cirrhosis as a driver to tackle preventable mortality and morbidity nationally and regionally.
2023cited by 0position: contributordoi
Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.
2022cited by 231position: contributordoi
Non-invasive alloimmune risk stratification of long-term liver transplant recipients
Journal of Hepatology 2021cited by 53position: middledoi
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK
The Lancet 2021cited by 41position: middledoi
Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
2021cited by 40position: contributordoi
Remote Consultations Versus Standard Face-to-Face Appointments for Liver Transplant Patients in Routine Hospital Care: Feasibility Randomized Controlled Trial of myVideoClinic.
2021cited by 22position: contributordoi
Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
2020cited by 128position: contributordoi
Review article: chronic liver disease and pregnancy.
2020cited by 16position: contributordoi
Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascites.
2020cited by 0position: contributordoi
Remote Consultations Versus Standard Face-to-Face Appointments for Liver Transplant Patients in Routine Hospital Care: Feasibility Randomized Controlled Trial of myVideoClinic (Preprint)
2020cited by 0position: contributordoi
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
The Lancet 2019cited by 78position: middledoi
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK
The Lancet 2018cited by 64position: middledoi
New metrics for the Lancet Standing Commission on Liver Disease in the UK
The Lancet 2016cited by 42position: middledoi
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
The Lancet 2014cited by 600position: middledoi

Grants

Equipment: University of Hawaii R/V Kilo Moana Oceanographic Instrumentation
NSF2315291$61,8792023–2025PIRePORTER
University of Hawaii R/V Kilo Moana Oceanographic Instrumentation
NSF2218702$202,5252022–2024PIRePORTER
University of Hawaii R/V Kilo Moana Oceanographic Instrumentation
NSF2016843$17,2102020–2021PIRePORTER
R/V Kilo Moana CTD Winch and Launch and Recovery System
NSF1922693$501,6972019–2021PIRePORTER
Oceanographic Technical Support 2018-2022 - R/V Kilo Moana
NSF1822905$11,224,5732018–2025PIRePORTER
University of Hawaii R/V Kilo Moana Oceanographic Instrumentation - 2016
NSF1624433$96,4522016–2017PIRePORTER
University of Hawaii R/V Kilo Moana Oceanographic Instrumentation - 2015
NSF1523550$68,1632015–2016PIRePORTER
STTR Phase I: Customized Manufacture of Protective Headgear for Mitigation of Fall Related Injuries
NSF1417120$224,6472014–2015PIRePORTER
University of Hawaii R/V Kilo Moana Oceanographic Instrumentation - 2014
NSF1421936$62,6502014–2015PIRePORTER
University of Hawaii Oceanographic Instrumentation CY2013
NSF1322167$163,3112013–2016PIRePORTER
Equipment For Agricultural Meteorology
NSF8013410$19,2111980–1983PIRePORTER

Frequent collaborators

· 16 papers (2020–2026)Alberto Sánchez‐Fueyo · King's College London3 papers (2021–2025)Juan G. Abraldeṣ · University of Alberta3 papers (2021–2025)Abdel Douiri · King's College London3 papers (2021–2025) · 3 papers (2021–2025)Sarah L. Damery · University of Birmingham3 papers (2020–2022)Déirdre Kelly · Princess Margaret Cancer Centre2 papers (2014–2024)Palak Trivedi · University of Amsterdam2 papers (2025–2026)Richard Taubert · Medizinische Hochschule Hannover2 papers (2021–2025) · 2 papers (2023–2024)Jeremy Shanika Nayagam · King's College - North Carolina2 papers (2023–2024)Richard Lilford · Liverpool School of Tropical Medicine2 papers (2020–2021) · 2 papers (2025–2026)Pablo Ruiz · Instituto de Salud Carlos III2 papers (2021–2025)Kate Jolly · NIHR Birmingham Biomedical Research Centre2 papers (2020–2021) · 2 papers (2021–2025)Janet E. Jones · University of Birmingham2 papers (2020–2021)Elaine O'Connell Francischetto · Gloucestershire County Council2 papers (2020–2021) · 2 papers (2021–2025)Elmar Jaeckel · University Health Network2 papers (2025–2025)